Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Permanent Injunction of “Heartbeat” Abortion Ban in Ohio

Client Alert

On October 24, 2024, Hamilton County Common Pleas Judge Christian Jenkins held that Ohio’s six-week abortion ban (i.e., the “heartbeat” abortion ban) is unconstitutional under the state’s recently adopted reproductive rights amendment.

Ohio’s heartbeat law banned abortion once a heartbeat was detected and as early as six weeks into a pregnancy. The heartbeat law criminalized medical providers who rendered abortion care when a heartbeat was detected; penalties included felony charges, $20,000 fines, medical license suspension and revocation, and civil claims.

Attorney General Dave Yost previously argued that the heartbeat abortion ban could still take effect in Ohio despite passage in November 2023 of an abortion rights constitutional amendment. Judge Jenkins disagreed, holding that Ohio’s constitutional reproductive rights amendment is unambiguous and clearly represents the will of Ohio’s voters. According to Jenkins, the constitutional amendment must be given full effect, and any state laws, including the heartbeat law, that contradict it, must be enjoined.

The practical significance of this ruling is to provide clarity to medical providers regarding their ability to provide women’s health care without facing criminal, civil, or financial penalties, or actions against their license.

If you have questions about the ruling, or Ohio’s reproductive rights amendment, please contact BMD Healthcare Member Daphne Kackloudis at dlkackloudis@bmdllc.com  or Attorney Jordan Burdick at jaburdick@bmdllc.com.


Name, Image, and Likeness Agreements in Healthcare

For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.

Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.

Top Compliance Risks for Ohio Med-Spas in 2025

The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.

Pre and Postnuptial Agreements | Necessary, Maybe, What Happened to Forever?

Both Florida and Ohio now allow clients to enter into a prenuptial or postnuptial agreement prior to marriage or after marriage (Ohio previously did not allow postnuptial agreements). Both documents have statutory guidelines that must be followed in terms of execution and financial disclosure.

DHS Ends All Employment Authorization Auto-Extensions

Effective October 30, 2025, DHS ends all automatic work authorization renewals. The 540-day extension applies only to renewals filed before this date, and there is no grace period for expired EADs filed on or after October 30. Employers must audit EADs, train staff, ensure I-9 compliance, and plan for work authorization gaps. Penalties for noncompliance can be severe.